Patient Designed Therapy Provides Possible “Natural” Selection Evidence for Testosterone as Differentiating Agent for High-Grade Prostate Cancer

Shaw GL Wilson P Cuzick J Prowse DM Goldenberg SL Spry NA International study into the use of intermittent hormone therpapy in the treatment of carcinoma of the prostate: a meta analysis of 1446 patients. BJU International 2007;99:1056–65.

Huggins C Hodges C . Studies on prostatic cancer 1: the effect of castration of estrogen and the androgen injection on serum phosphatases in metastatic carcioma of the prosate. Cancer Research 1941;I:293–7.

Prehn RT . On the prevention and therapy of prostate cancer by androgen administration. Cancer Research 1999;59(September (17):4161–4.

Slater S Oliver RT . Testosterone: its role in development of prostate cancer and potential risk from use as hormone replacement therapy. Drugs & Aging 2000;17(6):431–9.

Morgentaler A . Testosterone and prostate cancer: an historical perspective on a modern myth. European Urology 2006;50(5):935–9.

Morales A Connolly JG Burr RC Bruce AW . The use of radioactive phosphorous to treat bone pain in metastatic carcinoma of the prostate. Canadian Medical Association Journal 1970;103:372–3.

Morales A . Testosterone and prostate health: debunking myths demands evidence, caution, and good clinical judgment. European urology 2006;50:895–7.

San Francisco IF Regan MM Dewolf WC Olumi AF . Low age adjusted free testosterone levels correlate with poorly differentiated prostate cancer. Journal of Urology 2006;175(4):1341–5 [discussion 1345–6].

Kirby R Robertson C Turkes A Griffiths K Denis LJ Boyle P Finasteride in association with either flutamide or goserelin as combination hormonal therapy in patients with stage M1 carcinoma of the prostate gland International Prostate Health Council (IPHC) Trial Study Group. The Prostate 1999;40(July (2):105–14.

San Francisco IF Regan MM DeWolf WC Olumi AF Morales A . Re: low age adjusted free testosterone levels correlate with poorly differentiated prostate cancer. Journal of Urology 2006;175:1341–6 [The Journal of Urology 2006 Dec;176(6 Pt 1):2746; author reply].

Stoll BA . Hypothesis: breast cancer regression under oestrogen therapy. British Medical Journal 1973;3(August (5877):446–50.

Cusick JGF Kattan MW Berney D Oliver T Foster CS Moller H On behalf of the Transatlantic Prostate Group. Long-term outcome among men with conservatively treated localised prostate cancer. British Journal of Cancer 2006;95(November (9):1186–94.